|
| 38091751 | Neurite-based white matter alterations in MAPT mutation carriers: A multi-shell diffusion MRI study in the ALLFTD consortium. | Neurobiol Aging | 2024 |
| 37839080 | C9orf72 Repeat Expansion Initially Presenting as Late-Onset Bipolar Disorder With Psychosis. | Neurologist | 2024 |
| 37988272 | Clinical dimensions along the non-fluent variant primary progressive aphasia spectrum. | Brain | 2024 |
| 37769652 | Neural basis of speech and grammar symptoms in non-fluent variant primary progressive aphasia spectrum. | Brain | 2024 |
| 37639492 | Plasma phosphorylated tau-217 exhibits sex-specific prognostication of cognitive decline and brain atrophy in cognitively unimpaired adults. | Alzheimers Dement | 2024 |
| 36374516 | Association of Physical Activity With Neurofilament Light Chain Trajectories in Autosomal Dominant Frontotemporal Lobar Degeneration Variant Carriers. | JAMA Neurol | 2023 |
| 37918868 | [<sup>18</sup>F]PI-2620 Binding Patterns in Patients with Suspected Alzheimer Disease and Frontotemporal Lobar Degeneration. | J Nucl Med | 2023 |
| 37961381 | FTLD targets brain regions expressing recently evolved genes. | medRxiv | 2023 |
| 37848035 | Accelerating Alzheimer's therapeutic development: The past and future of clinical trials. | Cell | 2023 |
| 37740209 | Head-to-head comparison between plasma p-tau217 and flortaucipir-PET in amyloid-positive patients with cognitive impairment. | Alzheimers Res Ther | 2023 |
| 37942088 | Longitudinal clinical, cognitive and biomarker profiles in dominantly inherited versus sporadic early-onset Alzheimer's disease. | Brain Commun | 2023 |
| 37725166 | Co-pathology may impact outcomes of amyloid-targeting treatments: clinicopathological results from two patients treated with aducanumab. | Acta Neuropathol | 2023 |
| 37563165 | Frontotemporal lobar degeneration. | Nat Rev Dis Primers | 2023 |
| 37317972 | Tau pathology in neurodegenerative disease: disease mechanisms and therapeutic avenues. | J Clin Invest | 2023 |
| 37180971 | Feasibility and acceptability of remote smartphone cognitive testing in frontotemporal dementia research. | Alzheimers Dement (Amst) | 2023 |
| 36977552 | Plasma inflammation for predicting phenotypic conversion and clinical progression of autosomal dominant frontotemporal lobar degeneration. | J Neurol Neurosurg Psychiatry | 2023 |
| 37010841 | Evaluation of Plasma Phosphorylated Tau217 for Differentiation Between Alzheimer Disease and Frontotemporal Lobar Degeneration Subtypes Among Patients With Corticobasal Syndrome. | JAMA Neurol | 2023 |
| 37075703 | Meta-analysis of published cerebrospinal fluid proteomics data identifies and validates metabolic enzyme panel as Alzheimer's disease biomarkers. | Cell Rep Med | 2023 |
| 37464408 | Single-cell RNA-seq reveals alterations in peripheral CX3CR1 and nonclassical monocytes in familial tauopathy. | Genome Med | 2023 |
| 37431188 | Network Connectivity Alterations across the MAPT Mutation Clinical Spectrum. | Ann Neurol | 2023 |
| 37364279 | Presence of Preoperative Neurodegeneration Biofluid Markers in Patients with Postoperative Delirium. | Anesthesiology | 2023 |
| 37461624 | Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies <i>LRRC4C, LHX5-AS1</i> and nominates ancestry-specific loci <i>PTPRK</i> , <i>GRB14</i> , and <i>KIAA0825</i> as novel risk loci for Alzheimer's disease: the Alzheimer's Disease Genetics Consortium. | medRxiv | 2023 |
| 36591730 | Multisite ALLFTD study modeling progressive empathy loss from the earliest stages of behavioral variant frontotemporal dementia. | Alzheimers Dement | 2023 |
| 36446586 | Radiogenomics of <i>C9orf72</i> Expansion Carriers Reveals Global Transposable Element Derepression and Enables Prediction of Thalamic Atrophy and Clinical Impairment. | J Neurosci | 2023 |
| 36873926 | Development, initial validation, and application of a visual read method for [<sup>18</sup>F]MK-6240 tau PET. | Alzheimers Dement (N Y) | 2023 |
| 36938523 | Uncovering spatiotemporal patterns of atrophy in progressive supranuclear palsy using unsupervised machine learning. | Brain Commun | 2023 |
| 34158138 | Lower White Matter Volume and Worse Executive Functioning Reflected in Higher Levels of Plasma GFAP among Older Adults with and Without Cognitive Impairment. | J Int Neuropsychol Soc | 2022 |
| 35845260 | Hepatic and renal function impact concentrations of plasma biomarkers of neuropathology. | Alzheimers Dement (Amst) | 2022 |
| 35710320 | Plasma neurofilament light chain levels suggest neuroaxonal stability following therapeutic remyelination in people with multiple sclerosis. | J Neurol Neurosurg Psychiatry | 2022 |
| 35584922 | Sensitivity of the Social Behavior Observer Checklist to Early Symptoms of Patients With Frontotemporal Dementia. | Neurology | 2022 |
| 35510092 | Comparison of plasma and CSF biomarkers across ethnoracial groups in the ADNI. | Alzheimers Dement (Amst) | 2022 |
| 35349636 | Proposed research criteria for prodromal behavioural variant frontotemporal dementia. | Brain | 2022 |
| 35377391 | Subcortical Neuronal Correlates of Sleep in Neurodegenerative Diseases. | JAMA Neurol | 2022 |
| 35731122 | Right temporal degeneration and socioemotional semantics: semantic behavioural variant frontotemporal dementia. | Brain | 2022 |
| 35542994 | Therapeutic Targets for Alzheimer's Disease: Amyloid Vs. Non-Amyloid. Where Does Consensus Lie Today? An CTAD Task Force Report. | J Prev Alzheimers Dis | 2022 |
| 35577574 | Plasma P-tau181 and P-tau217 in Patients With Traumatic Encephalopathy Syndrome With and Without Evidence of Alzheimer Disease Pathology. | Neurology | 2022 |
| 35790423 | Differences in Motor Features of <i>C9orf72</i>, <i>MAPT</i>, or <i>GRN</i> Variant Carriers With Familial Frontotemporal Lobar Degeneration. | Neurology | 2022 |
| 35363932 | A Modified Progressive Supranuclear Palsy Rating Scale for Virtual Assessments. | Mov Disord | 2022 |
| 35486397 | Diagnostic Accuracy of Magnetic Resonance Imaging Measures of Brain Atrophy Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Degeneration. | JAMA Netw Open | 2022 |
| 36694576 | The role of neurofilament light in genetic frontotemporal lobar degeneration. | Brain Commun | 2022 |
| 36424467 | CSF tau microtubule-binding region identifies pathological changes in primary tauopathies. | Nat Med | 2022 |
| 35908251 | The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease. | Alzheimers Dement | 2022 |
| 36030718 | Detection of emerging neurodegeneration using Bayesian linear mixed-effect modeling. | Neuroimage Clin | 2022 |
| 34854532 | The contribution of behavioral features to caregiver burden in FTLD spectrum disorders. | Alzheimers Dement | 2022 |
| 35182511 | Advances and controversies in frontotemporal dementia: diagnosis, biomarkers, and therapeutic considerations. | Lancet Neurol | 2022 |
| 35173015 | Cerebrospinal Fluid Biomarkers in Autopsy-Confirmed Alzheimer Disease and Frontotemporal Lobar Degeneration. | Neurology | 2022 |
| 34581500 | Current directions in tau research: Highlights from Tau 2020. | Alzheimers Dement | 2022 |
| 33215319 | The impact of demographic, clinical, genetic, and imaging variables on tau PET status. | Eur J Nucl Med Mol Imaging | 2021 |
| 33590953 | Sex differences in the behavioral variant of frontotemporal dementia: A new window to executive and behavioral reserve. | Alzheimers Dement | 2021 |
| 33704477 | Diagnostic Utility of Measuring Cerebral Atrophy in the Behavioral Variant of Frontotemporal Dementia and Association With Clinical Deterioration. | JAMA Netw Open | 2021 |